Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.

Autelitano, D J; Clements, J A; Nikolaidis, I; Canny, B J; Funder, J W

Autelitano, D J; Clements, J A; Nikolaidis, I; Canny, B J; Funder, J W.

Affiliation

Autelitano DJ; Medical Research Centre, Prince Henry's Hospital, Melbourne, Victoria Australia.

Endocrinology ; 121(5): 1689-96, 1987 Nov.

Article in En | MEDLINE | ID: mdl-2959468

Subject(s)

Bromocriptine/pharmacology; Dexamethasone/pharmacology; Dopamine/physiology; Haloperidol/pharmacology; Pituitary Gland, Anterior/metabolism; Pituitary Gland, Posterior/metabolism; Pro-Opiomelanocortin/genetics; RNA, Messenger/genetics; beta-Endorphin/metabolism; Animals; DNA/metabolism; Hypothalamus/drug effects; Hypothalamus/metabolism; Male; Nucleic Acid Hybridization; Pituitary Gland, Anterior/drug effects; Pituitary Gland, Posterior/drug effects; Prolactin/genetics; RNA, Messenger/drug effects; RNA, Messenger/metabolism; Rats; Rats, Inbred Strains

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Gland, Anterior / Pituitary Gland, Posterior / Pro-Opiomelanocortin / RNA, Messenger / Dexamethasone / Beta-Endorphin / Dopamine / Bromocriptine / Haloperidol Limits: Animals Language: En Journal: Endocrinology Year: 1987 Type: Article

Search on Google

XML

PubMed Links